Sex differences in myocarditis hospitalizations: Rates, outcomes, and hospital characteristics in the National Readmission Database.

Myocarditis Resource utilization Sex/gender difference

Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
03 Dec 2023
Historique:
received: 23 11 2023
accepted: 28 11 2023
pubmed: 6 12 2023
medline: 6 12 2023
entrez: 5 12 2023
Statut: aheadofprint

Résumé

Inflammation of the myocardium, or myocarditis, presents with varied severity, from mild to life-threatening such as cardiogenic shock or ventricular tachycardia storm. Existing data on sex-related differences in its presentation and outcomes are scarce. Using the Nationwide Readmission Database (2016-2019), we identified myocarditis hospitalizations and stratified them according to sex to either males or females. Multivariable regression analyses were used to determine the association between sex and myocarditis outcomes. The primary outcome was in-hospital mortality, and the secondary outcomes included sudden cardiac death (SCD), cardiogenic shock (CS), use of mechanical circulatory support (MCS), and 90-day readmissions. We found a total of 12,997 myocarditis hospitalizations, among which 4,884 (37.6 %) were females. Compared to males, females were older (51 ± 15.6 years vs. 41.9 ± 14.8 in males) and more likely to have connective tissue disease, obesity, and a history of coronary artery disease. No differences were noted between the two groups with regards to in-hospital mortality (adjusted odds ratio [aOR] 1.20; confidence interval [CI] 0.93-1.53; P = 0.16), SCD (aOR:1.18; CI 0.84-1.64; P = 0.34), CS (aOR: 1.01; CI 0.85-1.20;P = 0.87), or use of MCS (aOR: 1.07; CI:0.86-1.34; P = 0.56). In terms of interventional procedures, females had lower rates of coronary angiography (aOR: 0.78; CI 0.70-0.88; P < 0.01), however, similar rates of right heart catheterization (aOR 0.93; CI:0.79-1.09; P = 0.36) and myocardial biopsy (aOR: 1.16; CI:0.83-1.62; P = 0.38) compared to males. Additionally, females had a higher risk of 90-day all-cause readmission (aOR: 1.25; CI: 1.16-1.56; P < 0.01) and myocarditis readmission (aOR:1.58; CI 1.02-2.44; P = 0.04). Specific predictors of readmission included essential hypertension, congestive heart failure, malignancy, and peripheral vascular disease. In conclusion, females admitted with myocarditis tend to have similar in-hospital outcomes with males; however, they are at higher risk of readmission within 90 days from hospitalization. Further studies are needed to identify those at higher risk of readmission.

Identifiants

pubmed: 38052347
pii: S0146-2806(23)00650-3
doi: 10.1016/j.cpcardiol.2023.102233
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102233

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts to disclose.

Auteurs

Ahmed M Elzanaty (AM)

Department of Medicine, Division of Cardiovascular Medicine, Division of Cardiology, University of Toledo, 3000 Arlington Ave, Toledo, OH 43614, USA. Electronic address: ahmed.elzanaty@utoledo.edu.

Amro Aglan (A)

Department of Medicine, Beth Israel Lahey Health, Burlington, MA, USA.

Mohammed Yassen (M)

Department of Internal Medicine, University of Toledo, Toledo, OH, USA.

Rachel Royfman (R)

College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.

Ahmed Maraey (A)

Department of Medicine, University of North Dakota, Bismarck, ND, USA.

Mahmoud Khalil (M)

Department of Internal Medicine, Lincoln Medical Center, New York, NY, USA.

Meghana Ranabothu (M)

College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.

Shikha Lakhani (S)

College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.

Andrew Waack (A)

College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.

Eman Elsheikh (E)

Department of Internal Medicine, University of Toledo, Toledo, OH, USA.

Ehab Eltahawy (E)

Department of Medicine, Division of Cardiovascular Medicine, Division of Cardiology, University of Toledo, 3000 Arlington Ave, Toledo, OH 43614, USA.

Classifications MeSH